COVID-19 is associated with an increase in volume, citations, and attention for both COVID and non-COVID-related otolaryngology articles.
Modified Olfactory Training Is Effective in Treating Post–COVID-19 Parosmia
Parosmia has been reported to develop after COVID-19 and may be a sign of recovery in olfactory function following anosmia.
No Benefit to Using Povidone-Iodine over Saline as a Nasal Irrigation After Sinonasal Surgery
A dilute 0.1% PVP-I nasal irrigation as a postoperative care modality after rhinomanomesinonasal surgery does not provide additional benefit compared with normal saline irrigation.
Drug-Eluting Endotracheal Tubes May Prevent Bacterial Inflammation in Patients with Subglottic Stenosis
An effective eluting endotracheal tube to modulate upper-airway bacterial infection during intubation could be deployed to help prevent subglottic stenosis.
Commonly Used Clinical Doses of Ibuprofen Do Not Significantly Increase Risk of Post-Tonsillectomy Hemorrhage in Children
Post-tonsillectomy hemorrhage is a common and potentially life-threatening complication but there is no statistically significant increase in risk at the low or high range of commonly used clinical dosages.
More Research Needed to Evaluate Incorporation of Gamification in Medical Education Platforms
Despite many simulation studies and attempts to include it, the medical community has not fully embraced gamification within residency education.
What Is a Physician’s Obligation to Disclose ‘Near-Miss’ and ‘No-Harm’ Events to Patients?
The answer lies in three domains: our professional duties to the patient, our ethical obligations to the patient, and our fiduciary responsibilities to society.
Is Percutaneous Tracheostomy Safe?
The current literature unequivocally demonstrates that endoscopic percutaneous dilatational tracheostomy is at least as safe as open surgical tracheostomy.
When Is Antibiotic Prophylaxis for Nasal Packing Indicated?
The best practice recommendation is not to routinely use prophylactic antibiotics with nasal packing, as antibiotic use does not appear to reduce complications and is not cost-effective.
Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why?
Recurrent respiratory papillomatosis (RRP) is a potentially lethal disease caused by the human papillomavirus (HPV) and characterized by recurrent papillomas in the aerodigestive tract.
- « Previous Page
- 1
- …
- 56
- 57
- 58
- 59
- 60
- …
- 336
- Next Page »